中国输血设备市场投资潜力分析与发展前景建议报告2026-2032年版 【出版机构】：鸿晟信合研究院 【内容部分有删减·详细可参鸿晟信合研究院出版完整信息！】 1 输血设备市场概述 1.1 产品定义及统计范围 1.2.2 容量输液泵 1.2.3 重力输液泵 1.3 从不同应用，输血设备主要包括如下几个方面 1.3.1 中国不同应用输血设备增长趋势2021 VS 2025 VS 2032 1.3.2 医院 1.3.3 门诊手术中心 1.3.4 透析中心 1.3.5 其他 1.4 中国输血设备发展现状及未来趋势（2021-2032） 1.4.1 中国市场输血设备收入及增长率（2021-2032） 1.4.2 中国市场输血设备销量及增长率（2021-2032） 2 中国市场主要输血设备厂商分析 2.1 中国市场主要厂商输血设备销量及市场占有率 2.1.1 中国市场主要厂商输血设备销量（2021-2026） 2.2.3 2025年中国市场主要厂商输血设备收入排名 2.3 中国市场主要厂商输血设备价格（2021-2026） 2.4 中国市场主要厂商输血设备总部及产地分布 2.5 中国市场主要厂商成立时间及输血设备商业化日 ...

Group 1 - Loomis Sayles Small Cap Value Fund reported a return of 6.21% in Q3 2025, underperforming the Russell 2000 Value Index which returned 12.60% [1] - The strong performance of US equities in Q3 was attributed to easing tariff concerns, a pro-growth budget from Congress, and expectations of further rate cuts by the Federal Reserve [1] - The fund highlighted Alight, Inc. (NYSE:ALIT) as a significant stock, which experienced a one-month return of -15.45% and a 52-week decline of 71.20% [2][3] Group 2 - Alight, Inc. (NYSE:ALIT) closed at $1.97 per share on December 24, 2025, with a market capitalization of $1.082 billion [2] - The fund noted that the shift towards "risk-on" and "low-quality" stocks negatively impacted its performance due to a style mismatch with its high-quality investment approach [3] - Individual stocks such as Haemonetics Corporation, Alight, Inc. (NYSE:ALIT), and Kyndryl Holdings Incorporated were identified as the largest detractors from the fund's performance [3]

Core Insights - U.S. stocks experienced a decline, with the Dow Jones index dropping over 400 points on Thursday [1] - Datadog, Inc. reported strong third-quarter financial results, exceeding expectations, and raised its guidance for the fourth quarter and FY25 [1][2] Datadog, Inc. - Datadog's quarterly earnings were 55 cents per share, surpassing the analyst consensus estimate of 46 cents per share [2] - The company reported quarterly sales of $885.651 million, exceeding the analyst consensus estimate of $852.781 million [2] - Following the earnings report, Datadog shares surged 20% to $186.13 [2] Other Notable Stocks - Forge Global Holdings, Inc. shares increased by 67.6% to $43.80 after an acquisition agreement with Charles Schwab [4] - Golden Entertainment, Inc. gained 40% to $29.77 following an acquisition announcement at $30 per share [4] - Stagwell Inc. surged 38.2% to $6.65 after reporting better-than-expected third-quarter results and issuing FY25 sales guidance above estimates [4] - SiTime Corporation rose 37.5% to $383.00 after reporting strong quarterly results and receiving a price target increase from Needham [4] - Fastly, Inc. gained 28.3% to $10.35 after raising its full-year earnings and sales guidance [4] - Brighthouse Financial, Inc. increased by 27.3% to $65.94 following an acquisition agreement at $70 per share [4] - Hecla Mining Company rose 26.7% to $15.35 after reporting better-than-expected quarterly results [4] - Haemonetics Corporation gained 24% to $62.87 following positive quarterly results [4] - Forward Air Corporation jumped 23% to $21.75 after third-quarter results [4] - Warrior Met Coal, Inc. gained 21.3% to $80.10 after beating third-quarter earnings and revenue estimates, with a price target increase from BMO Capital [4] - Penumbra, Inc. jumped 20% to $270.56 after reporting strong quarterly results and raising FY25 sales guidance [4] - Coherent Corp. gained 14.3% to $153.84 after better-than-expected first-quarter results and issuing second-quarter sales guidance above estimates [4] - Planet Fitness, Inc. rose 11.4% to $102.16 after beating third-quarter earnings and revenue estimates [4] - Air Products and Chemicals, Inc. gained 10% to $261.19 after reporting better-than-expected quarterly adjusted EPS results and issuing FY26 adjusted EPS guidance above estimates [4] - Snap Inc. rose 10% to $8.03 after reporting better-than-expected third-quarter results [4] - WW International, Inc. gained 9% to $36.19 following third-quarter results [4]

Core Insights - The Royce Small-Cap Trust aims for long-term capital growth by investing at least 65% of its assets in equity securities of small- and micro-cap companies [8] Performance Summary - As of July 31, 2025, the Net Asset Value (NAV) is $17.06, while the market price is $15.18 [1] - The average annual total return for the NAV over the past five years is 11.24%, and for the market, it is 11.98% [1] - Year-to-date return for NAV is 4.53%, compared to a mere 0.02% for the market [1] Portfolio Diagnostics - The average market capitalization of the portfolio is $3.2075 billion [3] - The weighted average Price-to-Earnings (P/E) ratio is 18.5x, and the weighted average Price-to-Book (P/B) ratio is 2.1x [3] - The total net assets of the fund amount to $2.04 billion [3] Portfolio Composition - The top ten positions account for a significant portion of net assets, with IES Holdings at 2.1% and Assured Guaranty at 1.4% [7] - The largest sectors by net assets include Industrials (25.4%), Financials (22.5%), and Information Technology (14.4%) [7] Recent Developments - Royce Small-Cap Trust is a closed-end diversified management investment company listed on the New York Stock Exchange under the symbol RVT [8] - The fund has an average weekly trading volume of approximately 1,343,647 shares [6]

Core Insights - The Royce Small-Cap Trust is a closed-end diversified management investment company focused on long-term capital growth by investing primarily in small-cap and micro-cap companies [10][8] - As of June 30, 2025, the Fund's net asset value (NAV) is $16.74, while the market price (MKT) is $15.05, indicating a potential discount for investors [1] - The Fund's average annual total return for the one-year period is 10.37% for NAV and 13.43% for MKT, showing strong performance relative to the market [1] Performance Metrics - The Fund's average annual total return as of June 30, 2025, includes: - One-Month: NAV 4.56%, MKT 3.31% - Year to Date: NAV 2.57%, MKT -0.84% - Three-Year: NAV 13.54%, MKT 11.33% - Five-Year: NAV 12.18%, MKT 12.78% - Ten-Year: NAV 9.46%, MKT 9.82% [1] - The Fund's net assets total $2.00 billion, with an average market capitalization of $3.06 billion [4] Portfolio Composition - The top ten positions in the Fund account for the following percentages of net assets: - IES Holdings: 1.8% - Assured Guaranty: 1.5% - SEI Investments: 1.4% - Other notable positions include PAR Technology, E-L Financial, and APi Group, each contributing between 1.0% and 1.3% [7][9] - The Fund's sector allocation is as follows: - Industrials: 24.4% - Financials: 23.3% - Information Technology: 14.5% - Health Care: 9.9% - Consumer Discretionary: 9.6% [10] Investment Strategy - The Fund aims to invest at least 65% of its assets in equity securities of small- and micro-cap companies, which may involve higher risks compared to larger-cap investments [10][3] - The Fund's investment adviser has over 50 years of experience in small- and micro-cap investments, indicating a strong expertise in this niche market [8]

Group 1 - Integer Holdings Corporation has appointed Michael Coyle to its Board of Directors, bringing over 40 years of leadership experience in the medical device industry [1][2] - Coyle's previous roles include president and CEO of iRhythm Technologies and executive vice president at Medtronic, along with leadership positions at St. Jude Medical and Eli Lilly [2] - He holds a master's degree from the Wharton School and a bachelor's degree from Case Western Reserve University, along with six U.S. patents related to cardiovascular medical devices [3] Group 2 - The Board of Integer regularly evaluates its composition to ensure it has the necessary skills and perspectives for growth [4] - Coyle's extensive experience is expected to significantly contribute to Integer's strategic initiatives and corporate culture [4] - The executive leadership team anticipates that Coyle's expertise will enhance Integer's contract development and manufacturing outsourcing strategy [4][5]